An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: statement on influenza vaccination for the 2003-04 season.
Identifieur interne : 000925 ( Main/Exploration ); précédent : 000924; suivant : 000926An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: statement on influenza vaccination for the 2003-04 season.
Auteurs : T. Tam ; J. LangleySource :
- Canada communicable disease report = Releve des maladies transmissibles au Canada [ 1188-4169 ] ; 2004.
Descripteurs français
- KwdFr :
- MESH :
- ressources et distribution : Vaccins antigrippaux.
- épidémiologie : Canada, Grippe humaine.
- Comités consultatifs, Enfant, Grippe humaine, Humains, Sujet âgé, Surveillance de la population.
- Wicri :
- geographic : Canada.
English descriptors
- KwdEn :
- MESH :
- chemical , supply & distribution : Influenza Vaccines.
- geographic , epidemiology : Canada.
- epidemiology : Influenza, Human.
- prevention & control : Influenza, Human.
- Advisory Committees, Aged, Child, Humans, Population Surveillance.
Abstract
The National Advisory Committee on Immunization (NACI) provides Health Canada with ongoing and timely medical, scientific, and public health advice relating to immunization. Health Canada acknowledges that the advice and recommendations set out in this statement are based upon the best current available scientific knowledge and is disseminating this document for information purposes. People administering or using the vaccine should also be aware of the contents of the relevant product monograph(s). Recommendations for use and other information set out herein may differ from that set out in the product monograph(s) of the Canadian licensed manufacturer(s) of the vaccine(s). Manufacturer(s) have sought approval of the vaccine(s) and provided evidence as to its safety and efficacy only when it is used in accordance with the product monographs.
PubMed: 15035403
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: statement on influenza vaccination for the 2003-04 season.</title><author><name sortKey="Tam, T" sort="Tam, T" uniqKey="Tam T" first="T" last="Tam">T. Tam</name></author><author><name sortKey="Langley, J" sort="Langley, J" uniqKey="Langley J" first="J" last="Langley">J. Langley</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15035403</idno><idno type="pmid">15035403</idno><idno type="wicri:Area/Main/Corpus">000995</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000995</idno><idno type="wicri:Area/Main/Curation">000995</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000995</idno><idno type="wicri:Area/Main/Exploration">000995</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: statement on influenza vaccination for the 2003-04 season.</title><author><name sortKey="Tam, T" sort="Tam, T" uniqKey="Tam T" first="T" last="Tam">T. Tam</name></author><author><name sortKey="Langley, J" sort="Langley, J" uniqKey="Langley J" first="J" last="Langley">J. Langley</name></author></analytic><series><title level="j">Canada communicable disease report = Releve des maladies transmissibles au Canada</title><idno type="ISSN">1188-4169</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Advisory Committees</term><term>Aged</term><term>Canada (epidemiology)</term><term>Child</term><term>Humans</term><term>Influenza Vaccines (supply & distribution)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Population Surveillance</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Canada (épidémiologie)</term><term>Comités consultatifs</term><term>Enfant</term><term>Grippe humaine ()</term><term>Grippe humaine (épidémiologie)</term><term>Humains</term><term>Sujet âgé</term><term>Surveillance de la population</term><term>Vaccins antigrippaux (ressources et distribution)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="supply & distribution" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Canada</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="ressources et distribution" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Canada</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Advisory Committees</term><term>Aged</term><term>Child</term><term>Humans</term><term>Population Surveillance</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Comités consultatifs</term><term>Enfant</term><term>Grippe humaine</term><term>Humains</term><term>Sujet âgé</term><term>Surveillance de la population</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The National Advisory Committee on Immunization (NACI) provides Health Canada with ongoing and timely medical, scientific, and public health advice relating to immunization. Health Canada acknowledges that the advice and recommendations set out in this statement are based upon the best current available scientific knowledge and is disseminating this document for information purposes. People administering or using the vaccine should also be aware of the contents of the relevant product monograph(s). Recommendations for use and other information set out herein may differ from that set out in the product monograph(s) of the Canadian licensed manufacturer(s) of the vaccine(s). Manufacturer(s) have sought approval of the vaccine(s) and provided evidence as to its safety and efficacy only when it is used in accordance with the product monographs.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15035403</PMID><DateCompleted><Year>2004</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2005</Year><Month>11</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1188-4169</ISSN><JournalIssue CitedMedium="Print"><Volume>30</Volume><PubDate><Year>2004</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Canada communicable disease report = Releve des maladies transmissibles au Canada</Title><ISOAbbreviation>Can. Commun. Dis. Rep.</ISOAbbreviation></Journal><ArticleTitle>An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: statement on influenza vaccination for the 2003-04 season.</ArticleTitle><Pagination><MedlinePgn>1-5</MedlinePgn></Pagination><Abstract><AbstractText>The National Advisory Committee on Immunization (NACI) provides Health Canada with ongoing and timely medical, scientific, and public health advice relating to immunization. Health Canada acknowledges that the advice and recommendations set out in this statement are based upon the best current available scientific knowledge and is disseminating this document for information purposes. People administering or using the vaccine should also be aware of the contents of the relevant product monograph(s). Recommendations for use and other information set out herein may differ from that set out in the product monograph(s) of the Canadian licensed manufacturer(s) of the vaccine(s). Manufacturer(s) have sought approval of the vaccine(s) and provided evidence as to its safety and efficacy only when it is used in accordance with the product monographs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tam</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Langley</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><CollectiveName>National Advisory Commitee on Immunization (NACI)</CollectiveName></Author></AuthorList><Language>eng</Language><Language>fre</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Can Commun Dis Rep</MedlineTA><NlmUniqueID>9303729</NlmUniqueID><ISSNLinking>1188-4169</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D026683" MajorTopicYN="Y">Advisory Committees</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000600" MajorTopicYN="Y">supply & distribution</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>3</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>4</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>3</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15035403</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Langley, J" sort="Langley, J" uniqKey="Langley J" first="J" last="Langley">J. Langley</name><name sortKey="Tam, T" sort="Tam, T" uniqKey="Tam T" first="T" last="Tam">T. Tam</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000925 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000925 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:15035403
|texte= An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: statement on influenza vaccination for the 2003-04 season.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:15035403" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |